HOXD13 and posterior cortical atrophy: Similarly, sPD-1 levels were found significantly higher among the patients compared to the matched healthy donors in lung adenocarcinoma, [11] aggressive prostate cancer (PCa), [12] papillary thyroid cancer, [13] and classical Hodgkin lymphoma (cHL) [14].